A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer

Cancer

Volumn 63, Issue 1, 1989, Pages 30-36

  Vokes, Everett E ^a,b   Schilsky, Richard L ^a,b   Choi Pharmd, Kyung E , ^a,b   Magid, Dawn M ^a,b   Guarnieri, Carol M ^a,b   Whaling, Susan M ^a,b   Ratain, Mark J ^a,b   Weichselbaum, Ralph R ^a,b   Panje, William R ^a,b  

^a Joint Section of Hematology Oncology ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; METHOTREXATE;

CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; HEAD AND NECK CANCER; HOSPITAL PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; OUTPATIENT; PRIORITY JOURNAL;

AMBULATORY CARE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATTITUDE TO HEALTH; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HOSPITALIZATION; HUMAN; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; METHOTREXATE; PATIENT COMPLIANCE; RANDOM ALLOCATION; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0024578468     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19890101)63:1<30::AID-CNCR2820630105>3.0.CO;2-M     Document Type: Article

References (22)

1. Continuous infusion or bolus injection in cancer chemotherapy
2. Continuous infusion chemotherapy: a critical review
3. Protracted ambulatory venous infusion of 5‐fluorouracil
4. Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia. A CALGB study
5. Intravenous vincristine infusion: Phase I trial
6. Vinblastine given as a continuous 5‐day infusion in the treatment of refractory advanced breast cancer
7. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5‐day infusion
8. Improved therapeutic index of bleomycin when administered by continuous infusion in mice
9. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
10. Comparison of continuously infused 5‐fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma
11. Improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120‐hour 5‐FU infusion and cisplatin
12. Portable infusion pumps in ambulatory cancer chemotherapy
13. Long‐term ambulatory treatment of metastatic colorectal adenocarcinoma by continuous intravenous infusion of 5‐fluorouracil
14. Ambulatory chemotherapy under continuous perfusion by portable pump: application trial
15. Sequential methotroxate, cisplatin and 5‐fluorouracil in multimodal therapy of locally advanced head and neck cancer
16. The two‐period cross‐over clinical trial
17. The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2‐deoxyurdine in man
18. Interpatient and intrapatient variability in vinblastine pharmacokinetics
19. Cardiotoxicity of 5‐fluorouracil
20. Weaver A, Cummings G, Al‐Sarraf M. A randomized trial of cisplatin (CACP) + 5‐fluorouracil (5‐FU) in fusion and CACP + 5‐FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck